Mouse PGK (phosphoglycerate kinase) promoter, Mouse PGK polyA (phosphoglycerate kinase gene terminater), E.coli Neomycin resistance gene, phage P1 loxP, Mouse polymerse (DNA directed), lambda genomic DNA Developed by Drs. Y. Kobayashi, K. Ikeda and N. Motoyama in National Institute for Longevity Sicences at 2000. Poll, polymerase (DNA directed), lambda gene knock out mice. Homozygous mutant mice show hydrocephalus and a high rate of mortality after birth. The surviving males are sterile due to spermatozoal immobility. Heterozygote x Wild-type (C57BL/6JJcl) 本山　昇 Noboru MOTOYAMA 2000年 池田恭二先生, 本山昇先生, 高井裕之先生, 山林洋介先生, 渡部美穂先生 国立長寿医療センター, 中外製薬株式会社 129とC57BL/6のF1 RBRC02900 B6;129P2-Poll<tm1Nmt> B6;129P2-Poll<tm1Nmt> C (3-6 months) 条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Mol. Cell Biol., 22, 2769-2776 (2002).<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>寄託者（開発者）の承諾を得る。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。 <a href='https://brc.riken.jp/mus/pcr02900'>Genotyping protocol -PCR-</a> C（3〜6か月） Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> 繁殖効率：A ヘテロ交配 ホモマウスは水頭症を発症する 2000年 池田恭二先生, 本山昇先生, 高井裕之先生, 山林洋介先生, 渡部美穂先生国立長寿医療センター, 中外製薬株式会社129とC57BL/6のF1 true POLL KO mice, DNA polymerase lamda KO mouse POLL KO mice, DNA polymerase lamda KO mouse 繁殖効率：Aヘテロ交配ホモマウスは水頭症を発症する DNA polymeraseのDNA修復に関する機能解析 In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Mol. Cell Biol., 22, 2769-2776 (2002).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT of BIOLOGICAL RESOURCE must obtain a prior written consent on use of it from the DEPOSITOR/DEVELOPER. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE.